Glycogen phosphorylase inhibition improves beta cell function

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|175|2|301-319

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.175, Iss.2, 2018-01, pp. : 301-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calpain Inhibition Improves Erectile Function in a Rat Model of Cavernous Nerve Injury

By  

Urologia Internationalis, Vol. 95, Iss. 2, 2015-02 ,pp. : 233-239

Karger

Access to resources Recommend Favorite

Glycogen synthase kinase‐3 inhibitor AR‐A014418 suppresses pancreatic cancer cell growth via inhibition of GSK‐3‐mediated Notch1 expression

By  

HPB, Vol. 17, Iss. 9, 2015-09 ,pp. : 770-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cellular models for beta‐cell function and diabetes gene therapy

By  

ACTA PHYSIOLOGICA (ELECTRONIC), Vol. 222, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gluten‐free diet increases beta‐cell volume and improves glucose tolerance in an animal model of type 2 diabetes

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 32, Iss. 7, 2016-10 ,pp. : 675-684

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imeglimin increases glucose‐dependent insulin secretion and improves β‐cell function in patients with type 2 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 541-545

John Wiley & Sons Inc

Access to resources Recommend Favorite